Unichem Labs standalone net profit declines 99.83 percent in Q3

Published On 2019-02-04 04:10 GMT   |   Update On 2019-02-04 04:10 GMT


Net Sales at Rs 244.76 crore in December 2018 up 53.82% from Rs. 159.12 crore in December 2017.


Mumbai: Mumbai based Unichem Laboratories Ltd. recently reported standalone quarterly results. The report showcase that the net profit of Unichem declined 99.83% to Rs 4.30 crore in the quarter ended December 2018 as against Rs 2507.03 crore during the previous quarter ended December 2017.


Sales rose 52.77% to Rs 244.76 crore in the quarter ended December 2018 as against Rs 160.21 crore during the previous quarter ended December 2017.


Earnings before interest, tax, depreciation and amortization (EBITDA) stands at Rs. 7.94 crores in December 2018 up 116.42% from Rs. 48.36 crore in December 2017.


Unichem Labs Earning Per Share has decreased to Rs. 0.61 in December 2018 from Rs. 275.74 in December 2017.




Unichem has several pharma products that address the needs of therapeutic areas.





Also Read: Apollo Hospitals Q4 net dips 43 per cent to Rs 36 crore

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News